I was thinking the opposite, given the bad news that is known so far, it should be easy to see the report in a positive light. We have seen a revenue and underlying EBITDA that only down 3% in 2nd half.
We have seen a bad statutory NPAT, down about 70% ($71m H1, $22m H2). The report will give an underlying NPAT and explain the significant items that bought it down.
We know one is the $25m writedown of Teva, which would bring underlying for H2 upto 47m, that leaves H2 still down $24m (or 33%), given that price erosion was claimed to be running at a 'high single digits' annually, and margins are around 50%, that only explains about 10% of the H2 drop (if the margin is 50% the effect of a 10% drop in prices will be doubled, but then halved because its only over 6 months)
So at the moment (by my reasoning) there is about a 23% drop in NPAT that hasn't been explained, the market is assuming the worst, because there is a lot of bad news around, but it might not be the case.
If the market is expecting a bad report, its easy to outdo expectations.
- Forums
- ASX - By Stock
- MYX
- Fundamentals Are Strong
Fundamentals Are Strong, page-769
-
- There are more pages in this discussion • 103 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.52 |
Change
-0.010(0.22%) |
Mkt cap ! $384.5M |
Open | High | Low | Value | Volume |
$4.48 | $4.58 | $4.46 | $324.8K | 72.12K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 434 | $4.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.56 | 4000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 8369 | 4.500 |
1 | 224 | 4.450 |
1 | 2000 | 4.440 |
1 | 1135 | 4.420 |
1 | 5000 | 4.410 |
Price($) | Vol. | No. |
---|---|---|
4.560 | 4000 | 1 |
4.600 | 2188 | 3 |
4.660 | 1097 | 1 |
4.670 | 1200 | 1 |
4.690 | 2287 | 1 |
Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |